ICD-10 Coding for Roseola(B08.2, B08.20, B08.20B)
Comprehensive guide on ICD-10 coding for roseola, including documentation requirements and clinical validation criteria.
Complete code families applicable to Roseola
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| B08.21 | Exanthema subitum due to human herpesvirus 6 | Use when lab-confirmed HHV-6 infection with classic roseola presentation is documented. |
|
| B08.22 | Exanthema subitum due to human herpesvirus 7 | Use when rash persists >48hrs with atypical features and HHV-7 is confirmed. |
|
| B08.20 | Exanthema subitum, unspecified | Use for typical presentation without specific viral testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutRoseola
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Roseola.
Failure to document lab confirmation for HHV-6 or HHV-7
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with coding guidelines., Financial: Potential denial of claims.
Mitigation
Ensure lab results are included in the medical record., Educate providers on documentation standards.
Coding B08.20 without definitive diagnosis
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Potential audit trigger for lack of specificity., Data Quality: Impacts accuracy of clinical data.
Mitigation
Query provider to confirm roseola infantum versus nonspecific viral rash.
Lack of specificity in viral etiology
Impact
Using unspecified codes without lab confirmation.
Mitigation
Require lab confirmation for specific viral codes.